-
ALS drug gets rare second review at high-stakes FDA meeting
A closely watched experimental drug for Lou Gehrig's disease got an unusual second look from U.S. regulators on Wednesday, following... Read more -
Gay, bisexual adults may be less likely to take needed high blood pressure medication
Gay and bisexual men and women appear less likely to take prescribed medications for high blood pressure than their straight... Read more -
FDA approves SPEVIGO for generalized pustular psoriasis flares
The U.S. Food and Drug Administration has approved SPEVIGO (spesolimab-sbzo) as the first treatment option for generalized pustular psoriasis (GPP)... Read more -
Pembrolizumab administration shown to not increase oral cavity surgery complications
A University of Cincinnati study found administering an immunotherapy drug before surgery for oral cavity cancer did not lead to... Read more -
Researchers discover potential new melanoma treatment, giving hope to patients
HMRI and University of Newcastle researchers have discovered that treating patients who have late-stage treatment resistant melanoma with a combination... Read more -
Antipsychotic use associated with elevated risk of breast cancer
A research team from the Center for Safe Medication Practice and Research (CSMPR), Department of Pharmacology and Pharmacy, LKS Faculty... Read more -
As CBD use rises, clinical trials needed to determine safety, efficacy in heart disease patients
As cannabidiol (CBD) use rises, high quality randomized clinical trials are needed to determine if anti-inflammatory benefits of CBD for... Read more -
Method to characterize pharmacokinetics and pharmacodynamics in the brain microregions
The brain is the most advanced organ with various complex structural and functional microregions. It is often challenging to understand... Read more -
FDA approves first treatment for acid sphingomyelinase deficiency
The U.S. Food and Drug Administration has approved Xenpozyme (olipudase alfa) for pediatric and adult patients with acid sphingomyelinase deficiency... Read more -
FDA still skeptical of ALS drug ahead of high-stakes meeting
Federal health regulators remain unconvinced about the benefits of a closely watched experimental drug for the debilitating illness known as... Read more -
Cannabis legalization decreases the stock market value of major pharmaceutical firms
Researchers from California Polytechnic State University and The University of New Mexico find that stock market investors predict cannabis legalization... Read more -
Researcher unlocks mystery of 'chemo-brain,' identifies possible treatment
Though chemotherapy can be lifesaving, the cancer treatment often leaves patients suffering from debilitating side effects, including cognitive impairments in... Read more -
Vamorolone effective, safe for boys with Duchenne muscular dystrophy
For boys with Duchenne muscular dystrophy (DMD), vamorolone, a structurally unique dissociative steroidal anti-inflammatory drug, is effective and safe over... Read more -
Following computational predictions, scientists demonstrate that cancer drug counters pulmonary fibrosis
An experimental cancer drug with a favorable safety profile shows promise as a treatment for Idiopathic Pulmonary Fibrosis (IPF), according... Read more -
Proxidrugs in the fight against pathogenic proteins
Cells have an efficient waste disposal system. Proxidrugs utilize this system as part of new treatments for cancer, infections and... Read more
